Pancreatic Cancer: Recruitment Rates and Trials Performance Statistics

We analyzed 981 clinical trials to check for their Recruitment Rates and assess countries based on their Average Recruitment Rate (patients/ site/ month).

The map below shows the regions with higher ARR in darker yellow. Where the highest is 2.97 patients/site/month and the lowest is 0.06 patients per site per month.

Map by TrialHub

If we look at Phase 3 only ranges vary between 0.12 and 5.92, where Phase 1 and 1/2 have 0.02 and 1.17 patients/site/month respectively. There is also a difference between clinical trials with observational purpose or treatment (highest here has been 2.86).

Looking at the highest recruiting countries, these are the top 5:

It is important to mention that all these rates are based on all sorts of clinical trials. If we are to focus on studies that target treatment, then countries like China, Brazil, and Ukraine are on top with their Recruitment Rates of 2.86, 1.74, 1.39 patients/site/month.

If you’d like to know more about planned vs actual trial performance in this indication you can download the Full Feasibility Report. Inside you’ll also find data on Prevalence, Countries with past experience, Competition analysis as well as Sites and Investigators. 

[activecampaign form=38]

TrialHub is a feasibility intelligence platform that supports feasibility, startup, patient recruitment and clinical project managers with a 360-degree overview of the clinical research landscape in order to plan successful and on-time clinical trials. 

TrialHub does this by aggregating thousands of data sources in real-time and combining them with local experts’ insights. 

The data provided in this article is gathered in November 2020 and is based on 17 clinical trial registries ( etc.) and analytics about thousands of clinical trials. 

If you want to get an up-to-date and/or customized feasibility for Pancreatic Cancer or need an assessment about a different indication or TA, please contact us at

Scroll to Top